Tuesday 24 May 2022 | 12:00 noon – Cape Town, SOUTH AFRICA
Chief Executive Officer – Yemaachi Biotech Ltd Accra, GHANA
Biotech – The next phase of African scientific capacity Development. Lessons learned over a year building an African biotech startup
(Host L. Donaldson)
Dr Yaw Bediako is a Ghanaian immunologist with a broad interest in investigating immune function among African populations in order to better address immunopathology associated with infectious and non-infectious diseases among these populations. He obtained his PhD at Northwestern University, Chicago, IL, and post-doctoral fellowships at the KEMRI-Wellcome Trust Programme in Kenya and subsequently at the Francis Crick Institute in London. In 2019 Dr Bediako took up a faculty appointment at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana and was one of 5 scientists selected in the inaugural round of the prestigious Crick Africa Network Fellowship.
In June 2020 he founded Yemaachi Biotech (www.yemaachi.com) an immunogenomics start-up based in Accra. Yemaachi’s vision is to lower the financial burden of disease on the African continent by leveraging state-of-the-art molecular and cellular biology to develop novel diagnostic tools and therapeutic agents, that work uniformly well irrespective of genetic background. In November 2021, Yaw was selected as a Calsestous Juma Science Leadership Felow by the Bill and Melinda Gates Foundation. Yaw is also a fellow of the Ghana Young Academy and an Affiliate member of the African Academy of Sciences.